As BMC of orlistat-administered tumor-bearing mice displayed an increased responsiveness to M-CSF for differentiation in Mφ lineage, we examined if these BMC also showed an altered expression of M-CSF and M-CSFR genes. The gene discussed is CSF1R; the disease is neoplasm.